The oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 revealed a manageable safety profile in relapsed ...

A picture-perfect Saturday morning for running and walking saw a healthy throng of athletes turn out for the Kinsley Ray 5K ...

Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment - immunotherapy - may help change the environment where cancer cells ...

Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of ...

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018 ...

Cytopenia at myelofibrosis diagnosis raises risk of acute myeloid leukemia and lowers survival, highlighting the need for ...

NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended regulators approve Servier's IDH1/2 inhibitor Voranigo (vorasidenib) as a treatment for ...

When you breathe out, you’re not just releasing carbon dioxide. Your breath carries a complex mix of volatile organic compounds, or VOCs—tiny molecules that come from normal body processes. These ...

Researchers conducted a retrospective study published in July 2025 issue of Journal of Hematology & Oncology to examine the ...

The team was surprised to discover that many patients who had mutations in certain genes linked to blood cancer—specifically ...

Philomath paddleboarder and his group encounter unusual weather phenomenon; Lions Club donates to help city upgrade its electronic marquee; and Frolic fundraiser helps cancer patients and their famili ...